DM
FLXN

Deerfield Management’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Deerfield Management’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-99,847
Closed -$2.02M – 135
2014
Q4 		$2.02M Buy
+99,847
New +$1.81M 0.07% 97

Other funds holding FLXN

GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Deerfield Management's FLXN Position: Q1 2015 in Review

Deerfield Management sold out of Flexion Therapeutics, Inc. (FLXN) in Q1 2015, closing a stake of 99,847 shares — an estimated $2.02M sold.

Deerfield Management first reported a position in FLXN in Q4 2014 and held it in 1 quarter. The position peaked at $2.02M in Q4 2014. 58 funds tracked by Wall St. Rank hold FLXN as of Q1 2015.

  • Deerfield Management reported no remaining Flexion Therapeutics, Inc. position as of Q1 2015 after selling out during the quarter.
  • Deerfield Management sold 99,847 Flexion Therapeutics, Inc. shares in Q1 2015, an estimated $2.02M.
  • Deerfield Management first reported a position in Flexion Therapeutics, Inc. in Q4 2014 and held it in 1 quarter.
  • Deerfield Management's Flexion Therapeutics, Inc. position peaked at $2.02M in Q4 2014.
  • 58 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q1 2015.

Based on Deerfield Management's 13F filing for Q1 2015, filed 15 May 2015.